x

75% of people globally want unbiased news (Pew Research) but are concerned they're not getting that.

Get balanced coverage with Symby. See how stories are covered across diverse outlets and spot when one side covers a story the other skips.

PODCAST

Molecule to Market: Inside the outsourcing space

Molecule to Market takes you inside the global pharma and biopharma outsourcing ecosystem. Each week, our host Raman Sehgal sits down with the founders, entrepreneurs, CEOs and C-suite leaders shaping the pharma services and tools that power discovery, drug development and commercialization. Listeners get real stories and practical insights from across the entire value chain, from big pharma and emerging biotechs to private equity investors, CROs, CDMOs, technology platforms and specialist

science life sciences

All Episodes

55:18

Mission-driven doctor, inventor & entrepreneur

Molecule to Market: Inside the outsourcing space ·

2024/06/13

In this episode of Molecule to Market, you’ll go inside the outsourcing space of the global drug development sector with Doctor Eric Edwards, Co-Founder and CEO at Phlow.Your host, Raman Sehgal, discusses the pharmaceutical and biotechnology supply chain with Eric, covering: How a life-threatening allergy for him and his identical twin brother led to a career in medicine and then an entrepreneurial journey in the pharma space The journey from inventors to becoming a commercial pharma

en

56:22

The boomerang boy impacting gene therapies

Molecule to Market: Inside the outsourcing space ·

2024/06/07

In this episode of Molecule to Market, you’ll go inside the outsourcing space of the global drug development sector with Andy Holt, CCO of Viralgen Vector Core.Your host, Raman Sehgal, discusses the pharmaceutical and biotechnology supply chain with Andy, covering: Growing a CDMO while dealmaking in a gene therapy company…at the same time Selling a revenue-generating therapy company to Bayer during the pandemic Faster failure or faster acceleration; the need to celebrate every gene therapy batch as

en

50:58

Taking on the biologics CDMOs from down under

Molecule to Market: Inside the outsourcing space ·

2024/05/31

In this episode of Molecule to Market, you’ll go inside the outsourcing space of the global drug development sector with Mark W. Womack, Chief Executive Officer at BioCina.Your host, Raman Sehgal, discusses the pharmaceutical and biotechnology supply chain with Mark, covering: How a tough upbringing in LA led him to the US Navy, and then onto a pathway into leadership Why he decided to end his own practice and jump into a senior role within a biopharma CDMO space The key factors that led him to

en

55:04

A true nerd of CGT

Molecule to Market: Inside the outsourcing space ·

2024/05/24

In this episode of Molecule to Market, you’ll go inside the outsourcing space of the global drug development sector with Bill Vincent, Founder and board chair at Genezen.Your host, Raman Sehgal, discusses the pharmaceutical and biotechnology supply chain with Bill, covering: The days when CGT therapies were viewed as just academic... then the events in 2012 that changed everything in the space How partnering with Indiana University for its vector capacity led to the creation of Genezen Building a

en

51:38

The virtual and decentralized clinical trials...

Molecule to Market: Inside the outsourcing space ·

2024/05/17

In this episode of Molecule to Market, you’ll go inside the outsourcing space of the global drug development sector with Helen Shaw and Dan Henley, co-founders of VCTC. Your host, Raman Sehgal, discusses the pharmaceutical and biotechnology supply chain with Helen and Dan, covering: Exposing your team to everything, letting them feel the pressure... but always being there to help and guide The founding story of VCTC... and the fun and games of dividing responsibilities as co-founders How the

en

51:02

Jumping into CDMO after a lifetime as a sponsor

Molecule to Market: Inside the outsourcing space ·

2024/05/10

In this episode of Molecule to Market, you’ll go inside the outsourcing space of the global drug development sector with Bill Humphries, CEO at Alcami. Your host, Raman Sehgal, discusses the pharmaceutical and biotechnology supply chain with Bill, covering: The role managers, leaders, and mentors have played in shaping his illustrious career in dermatology The importance of ‘force multiply’ in getting results and accelerating growth Why, after a career spent on the drug sponsor side... he decided to

en

54:12

Zero to a billion... A CDMO original - part 2

Molecule to Market: Inside the outsourcing space ·

2024/05/03

In this episode of Molecule to Market, you’ll go inside the outsourcing space of the global drug development sector for part 2 of our conversation with Thomas Eldered, Executive Chairman at Flerie.Your host, Raman Sehgal, discusses the pharmaceutical and biotechnology supply chain with Thomas, covering: The story behind Recipharm’s decision to divest Cobra Biologics that led Thomas to become owner How ‘big faith’ and the gene therapy revolution changed the fortunes of the loss-making biologics

en

01:04:10

Zero to a billion... A CDMO original - part 1

Molecule to Market: Inside the outsourcing space ·

2024/04/26

In this episode of Molecule to Market, you’ll go inside the outsourcing space of the global drug development sector with part 1 of our episode with Thomas Eldered, Executive Chairman at Flerie. Your host, Raman Sehgal, discusses the pharmaceutical and biotechnology supply chain with Thomas, covering: Where his entrepreneurial spark originated, and how they created a CMO (before that was even a thing) after several failed plans How did the timing of his first exit and having ‘cash during the

en

49:58

Dan’s the man...at Custom Biologics

Molecule to Market: Inside the outsourcing space ·

2024/04/19

In this episode of Molecule to Market, you’ll go inside the outsourcing space of the global drug development sector with Dan Mamelak, Founder & President at Custom Biologics.Your host, Raman Sehgal, discusses the pharmaceutical and biotechnology supply chain with Dan, covering: How reading The Billion-dollar Molecule book inspired him to explore a pathway into cutting-edge drug development The founding story of his company and some timeless advice not to burn bridges How the Canadian conveyor

en

20:14

Celebrating female talent in life sciences

Molecule to Market: Inside the outsourcing space ·

2024/04/05

In this episode of Molecule to Market, you’ll go inside the outsourcing space of the global drug development sector with: Denise Bowser from Onyx Scientific Audrey Greenberg from SK Pharmteco Kendalle Burlin O’Connell from MassBio Elisabeth Stampa from Medicines For Europe Sabina Ouimet-Storrs from GHO Capital In this episode, we feature highlights from recent interviews with some of the most inspiring women in the life sciences industry. These women sat down with host, Raman Sehgal, to share

en

45:53

The power of peptides

Molecule to Market: Inside the outsourcing space ·

2024/03/28

In this episode of Molecule to Market, you’ll go inside the outsourcing space of the global drug development sector with Alastair Hay, Vice President of Peptides at Almac Sciences.Your host, Raman Sehgal, discusses the pharmaceutical and biotechnology supply chain with Alastair, covering: The story behind Almac’s early bet of getting into the peptide game Behind the scenes of the incredible growth journey of Almac from a few hundred to 7000+ people... and some insight into the secret sauce behind

en

49:40

From Pfizer to CDMO carve-out

Molecule to Market: Inside the outsourcing space ·

2024/03/22

In this episode of Molecule to Market, you’ll go inside the outsourcing space of the global drug development sector with Brett Alderson, President and Site Leader of Novacina.Your host, Raman Sehgal, discusses the pharmaceutical and biotechnology supply chain with Brett, covering: The complexities of being on the inside of big pharma looking to carve out your site... then transitioning into a customer-facing CDMO Leaning into the freedom and liberation of having the shackles off as an independent

en

01:06:45

One-hour special: Meet the next big thing in obesity

Molecule to Market: Inside the outsourcing space ·

2024/03/15

In this episode of Molecule to Market, you’ll go inside the outsourcing space of the global drug development sector with Arvid Söderhall, CEO at Empros Pharma. Your host, Raman Sehgal, discusses the pharmaceutical and biotechnology supply chain with Arvid, covering: The personal story of a pediatrician treating an obese child that led to the creation of Empros Pharma and its lead asset The 10-year journey from an idea to a successful Phase IIb trial... and what it felt like to reach the magic

en

57:41

M&A Roundtable and 2024 Predictions

Molecule to Market: Inside the outsourcing space ·

2024/03/08

In this episode of Molecule to Market, you’ll go inside the outsourcing space of the global drug development sector with:Sabina Ouimet-Storrs, Principal at GHO Capital Partners James West, Managing Director at Lincoln International Derek Hennecke, investor and board member in biopharma and cell therapy manufacturing Your host, Raman Sehgal, discusses the pharmaceutical and biotechnology ecosystem with his guests, covering: The year of the failed process in 2023... Which sub-segments of the pharma

en

43:23

Transforming a family pharma firm

Molecule to Market: Inside the outsourcing space ·

2024/03/01

In this episode of Molecule to Market, you’ll go inside the outsourcing space of the global drug development sector with Elisabeth Stampa, President Medicines for Europe and Board Chair at Medichem.Your host, Raman Sehgal, discusses the pharmaceutical and biotechnology supply chain with Elisabeth, covering: She took the reigns of the family pharmaceutical firm from her father The struggle of turning around the business through rationalization and divestment and critical lessons learned from a

en

55:02

From MassBio... to the world

Molecule to Market: Inside the outsourcing space ·

2024/02/23

In this episode of Molecule to Market, you’ll go inside the outsourcing space of the global drug development sector with Kendalle Burlin O’Connell, CEO and President of MassBio.Your host, Raman Sehgal, discusses the pharmaceutical and biotechnology supply chain with Kendalle, covering: The story behind how Massachusetts became one of the biggest biotech clusters in the world and why this ecosystem has such an energy Kendalle’s non-linear journey into MassBio and how she made an impact (and

en

47:09

From banking to biotech

Molecule to Market: Inside the outsourcing space ·

2024/02/16

Founder of the Center for Breakthrough Medicines - now part of SK Pharmteco. Your host, Raman Sehgal, discusses the pharmaceutical and biotechnology supply chain with Audrey, covering: How a career in real estate financial services led her to the world of cell & gene therapy The story of the creation of the Center for Breakthrough Medicines to its eventual sale and ‘fit’ with SK Pharmteco Why Philadelphia’s 'Cellicon Valley' is becoming one of the hottest life science clusters in the

en

47:42

Dealing with downturns... and the menopause.

Molecule to Market: Inside the outsourcing space ·

2024/02/09

In this episode of Molecule to Market, you’ll go inside the outsourcing space of the global drug development sector with Denise Bowser, Co-Founder and Commercial Director of Onyx Scientific. Your host, Raman Sehgal, discusses the pharmaceutical and biotechnology supply chain with Denise, covering: The founding story of Onyx and helping the company gain traction in the early years A lesson in M&A - being acquired as a great business and being allowed to thrive as a great business The non-secret,

en

54:48

The dealmaker now redefining commercialization

Molecule to Market: Inside the outsourcing space ·

2024/02/02

In this episode of Molecule to Market, you’ll go inside the outsourcing space of the global drug development sector with Dominic (Nick) Marasco, Executive President and Chief Commercial Officer at Envision Pharma Group. Your host, Raman Sehgal, discusses the pharmaceutical and biotechnology supply chain with Nick, covering: Building businesses, learning lots, and selling BioAgilytix With many options on the table... what was it that attracted him to Envision Pharma Group The real-life benefits and

en

51:21

The biotech CDMO planning to impact the US

Molecule to Market: Inside the outsourcing space ·

2024/01/26

In this episode of Molecule to Market, you’ll go inside the outsourcing space of the global drug development sector with Himanshu Gadgil, CEO at Enzene Biosciences. Your host, Raman Sehgal, discusses the pharmaceutical and biotechnology supply chain with Himanshu, covering: How a personal tragedy led him from the US to India on a mission to make an impact Shifting from a technical to commercial focus to launch several biosimilars in India and beyond Being at the inception of a big pharma

en

256 results

Similar Podcasts

Classic Radio Science Fiction

solgoodmedia.com

Mission to Mars

Inception Point Ai

The 365 Days of Astronomy

365DaysOfAstronomy.org

Creek Devil

william Jevning

UFO Chronicles Podcast

Nik Hunter